GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003450211 | Esophagus | ESCC | protein localization to chromosome | 70/8552 | 92/18723 | 2.54e-09 | 5.64e-08 | 70 |
GO:000702914 | Esophagus | ESCC | endoplasmic reticulum organization | 65/8552 | 87/18723 | 3.28e-08 | 6.08e-07 | 65 |
GO:00482844 | Esophagus | ESCC | organelle fusion | 94/8552 | 141/18723 | 3.72e-07 | 5.16e-06 | 94 |
GO:00070308 | Esophagus | ESCC | Golgi organization | 101/8552 | 157/18723 | 1.78e-06 | 2.10e-05 | 101 |
GO:00901743 | Esophagus | ESCC | organelle membrane fusion | 73/8552 | 110/18723 | 9.29e-06 | 8.88e-05 | 73 |
GO:007064612 | Esophagus | ESCC | protein modification by small protein removal | 95/8552 | 157/18723 | 1.25e-04 | 8.56e-04 | 95 |
GO:00610254 | Esophagus | ESCC | membrane fusion | 98/8552 | 163/18723 | 1.39e-04 | 9.41e-04 | 98 |
GO:00483083 | Esophagus | ESCC | organelle inheritance | 14/8552 | 15/18723 | 1.47e-04 | 9.85e-04 | 14 |
GO:00483133 | Esophagus | ESCC | Golgi inheritance | 14/8552 | 15/18723 | 1.47e-04 | 9.85e-04 | 14 |
GO:00165793 | Esophagus | ESCC | protein deubiquitination | 79/8552 | 139/18723 | 5.23e-03 | 1.97e-02 | 79 |
GO:0071168 | Esophagus | ESCC | protein localization to chromatin | 21/8552 | 31/18723 | 1.10e-02 | 3.70e-02 | 21 |
GO:000702911 | Liver | HCC | endoplasmic reticulum organization | 64/7958 | 87/18723 | 3.92e-09 | 1.04e-07 | 64 |
GO:00070302 | Liver | HCC | Golgi organization | 99/7958 | 157/18723 | 1.54e-07 | 2.85e-06 | 99 |
GO:004828411 | Liver | HCC | organelle fusion | 84/7958 | 141/18723 | 3.13e-05 | 3.20e-04 | 84 |
GO:00706461 | Liver | HCC | protein modification by small protein removal | 91/7958 | 157/18723 | 6.50e-05 | 5.92e-04 | 91 |
GO:00345021 | Liver | HCC | protein localization to chromosome | 55/7958 | 92/18723 | 6.12e-04 | 3.82e-03 | 55 |
GO:00165791 | Liver | HCC | protein deubiquitination | 78/7958 | 139/18723 | 8.13e-04 | 4.87e-03 | 78 |
GO:00901741 | Liver | HCC | organelle membrane fusion | 63/7958 | 110/18723 | 1.24e-03 | 6.85e-03 | 63 |
GO:0061025 | Liver | HCC | membrane fusion | 88/7958 | 163/18723 | 1.98e-03 | 1.00e-02 | 88 |
GO:00483081 | Liver | HCC | organelle inheritance | 12/7958 | 15/18723 | 3.56e-03 | 1.59e-02 | 12 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
VCPIP1 | SNV | Missense_Mutation | rs572240658 | c.431G>A | p.Gly144Asp | p.G144D | Q96JH7 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
VCPIP1 | SNV | Missense_Mutation | novel | c.2185A>C | p.Lys729Gln | p.K729Q | Q96JH7 | protein_coding | tolerated(0.05) | benign(0.058) | TCGA-A5-A2K5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VCPIP1 | SNV | Missense_Mutation | novel | c.3367C>A | p.His1123Asn | p.H1123N | Q96JH7 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.577) | TCGA-A5-A7WJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
VCPIP1 | SNV | Missense_Mutation | novel | c.336N>T | p.Lys112Asn | p.K112N | Q96JH7 | protein_coding | deleterious(0) | benign(0.351) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
VCPIP1 | SNV | Missense_Mutation | novel | c.2926N>A | p.Glu976Lys | p.E976K | Q96JH7 | protein_coding | deleterious(0.01) | possibly_damaging(0.824) | TCGA-AJ-A3QS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
VCPIP1 | SNV | Missense_Mutation | | c.1882N>G | p.Lys628Glu | p.K628E | Q96JH7 | protein_coding | tolerated(0.21) | benign(0.062) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VCPIP1 | SNV | Missense_Mutation | | c.1740N>T | p.Trp580Cys | p.W580C | Q96JH7 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VCPIP1 | SNV | Missense_Mutation | | c.3437N>T | p.Ser1146Phe | p.S1146F | Q96JH7 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.946) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VCPIP1 | SNV | Missense_Mutation | | c.3520N>G | p.Thr1174Ala | p.T1174A | Q96JH7 | protein_coding | tolerated_low_confidence(0.21) | benign(0) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
VCPIP1 | SNV | Missense_Mutation | novel | c.1850N>T | p.Ser617Phe | p.S617F | Q96JH7 | protein_coding | deleterious(0) | benign(0) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |